|
Group
|
Characteristics
|
Number (%)
|
|---|
|
Sex
| | |
| |
Male
|
73(76.04%)
|
| |
Female
|
23(23.96%)
|
|
Age
| | |
| |
<60
|
54(56.25%)
|
| |
≥60
|
42(43.75%)
|
|
Pack years of smoking
| | |
| |
>40
|
47(48.96%)
|
| |
20.1–40
|
4(4.17%)
|
| |
0.1–20
|
8(8.33%)
|
| |
0
|
37(38.54%)
|
|
Histology
| | |
| |
LAC
|
41(42.71%)
|
| |
LSCC
|
39(40.63%)
|
| |
SCLC
|
11(11.46%)
|
| |
LCLC
|
3(3.13%)
|
| |
Undifferentiated
|
2(2.83%)
|
|
Pathologic grade
| | |
| |
Poorly differentiated
|
26(27.08%)
|
| |
Moderately differentiated
|
33(34.38%)
|
| |
Well-differentiated
|
21(21.88%)
|
| |
Others
|
16(16.67%)
|
|
Clinical staging
| | |
| |
IB
|
3(3.1%)
|
| |
IIA-IIB
|
53(55.3%)
|
| |
IIIA-IIIB
|
25(26.04%)
|
| |
IV
|
4(4.1%)
|
| |
Unavailable
|
11(11.46%)
|
|
Pleural invasion
| | |
| |
Absent
|
82(85.42%)
|
| |
Present
|
14(14.58%)
|
|
Lymphatic invasion
| | |
| |
Positive
|
55(57.29%)
|
| |
Negative
|
41(42.71%)
|
- LAC, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; SCLC, small cell lung cancer; LCLC, large cell lung cancer.
